318 related articles for article (PubMed ID: 32929330)
1. Dysregulated Kras/YY1/ZNF322A/Shh transcriptional axis enhances neo-angiogenesis to promote lung cancer progression.
Lin CC; Kuo IY; Wu LT; Kuan WH; Liao SY; Jen J; Yang YE; Tang CW; Chen YR; Wang YC
Theranostics; 2020; 10(22):10001-10015. PubMed ID: 32929330
[TBL] [Abstract][Full Text] [Related]
2. AKT-mediated phosphorylation enhances protein stability and transcription activity of ZNF322A to promote lung cancer progression.
Liao SY; Kuo IY; Chen YT; Liao PC; Liu YF; Wu HY; Lai WW; Wang YC
Oncogene; 2019 Oct; 38(41):6723-6736. PubMed ID: 31399647
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of microRNA-326 enhances ZNF322A expression, transcriptional activity and tumorigenic effects in lung cancer.
Huang SH; Hsieh HC; Shieh JM; Su WC; Wang YC
Biofactors; 2024; 50(1):214-227. PubMed ID: 37647209
[TBL] [Abstract][Full Text] [Related]
4. Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer.
Jen J; Lin LL; Chen HT; Liao SY; Lo FY; Tang YA; Su WC; Salgia R; Hsu CL; Huang HC; Juan HF; Wang YC
Oncogene; 2016 May; 35(18):2357-69. PubMed ID: 26279304
[TBL] [Abstract][Full Text] [Related]
5. IKKβ targeting reduces KRAS-induced lung cancer angiogenesis in vitro and in vivo: A potential anti-angiogenic therapeutic target.
Carneiro-Lobo TC; Scalabrini LC; Magalhães LDS; Cardeal LB; Rodrigues FS; Dos Santos EO; Baldwin AS; Levantini E; Giordano RJ; Bassères DS
Lung Cancer; 2019 Apr; 130():169-178. PubMed ID: 30885340
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic zinc finger protein ZNF322A promotes stem cell-like properties in lung cancer through transcriptional suppression of c-Myc expression.
Jen J; Liu CY; Chen YT; Wu LT; Shieh YC; Lai WW; Wang YC
Cell Death Differ; 2019 Jul; 26(7):1283-1298. PubMed ID: 30258097
[TBL] [Abstract][Full Text] [Related]
7. CK1δ/GSK3β/FBXW7α axis promotes degradation of the ZNF322A oncoprotein to suppress lung cancer progression.
Liao SY; Chiang CW; Hsu CH; Chen YT; Jen J; Juan HF; Lai WW; Wang YC
Oncogene; 2017 Oct; 36(41):5722-5733. PubMed ID: 28581525
[TBL] [Abstract][Full Text] [Related]
8. The USP21/YY1/SNHG16 axis contributes to tumor proliferation, migration, and invasion of non-small-cell lung cancer.
Xu P; Xiao H; Yang Q; Hu R; Jiang L; Bi R; Jiang X; Wang L; Mei J; Ding F; Huang J
Exp Mol Med; 2020 Jan; 52(1):41-55. PubMed ID: 31956270
[TBL] [Abstract][Full Text] [Related]
9. Endothelial specific YY1 deletion restricts tumor angiogenesis and tumor growth.
Liu H; Qiu Y; Pei X; Chitteti R; Steiner R; Zhang S; Jin ZG
Sci Rep; 2020 Nov; 10(1):20493. PubMed ID: 33235311
[TBL] [Abstract][Full Text] [Related]
10. Transcription Factor YY1 Modulates Lung Cancer Progression by Activating lncRNA-PVT1.
Huang T; Wang G; Yang L; Peng B; Wen Y; Ding G; Wang Z
DNA Cell Biol; 2017 Nov; 36(11):947-958. PubMed ID: 28972861
[TBL] [Abstract][Full Text] [Related]
11. Sonic Hedgehog-GLI Family Zinc Finger 1 Signaling Pathway Promotes the Growth and Migration of Pancreatic Cancer Cells by Regulating the Transcription of Eukaryotic Translation Initiation Factor 5A2.
Xu X; Liu H; Zhang H; Dai W; Guo C; Xie C; Wei S; He S; Xu X
Pancreas; 2015 Nov; 44(8):1252-8. PubMed ID: 26465952
[TBL] [Abstract][Full Text] [Related]
12. MiR-186 inhibits proliferation, migration, and invasion of non-small cell lung cancer cells by downregulating Yin Yang 1.
Huang T; Wang G; Yang L; Peng B; Wen Y; Ding G; Wang Z
Cancer Biomark; 2017 Dec; 21(1):221-228. PubMed ID: 29060934
[TBL] [Abstract][Full Text] [Related]
13. HOTAIR and androgen receptor synergistically increase GLI2 transcription to promote tumor angiogenesis and cancer stemness in renal cell carcinoma.
Bai JY; Jin B; Ma JB; Liu TJ; Yang C; Chong Y; Wang X; He D; Guo P
Cancer Lett; 2021 Feb; 498():70-79. PubMed ID: 33157157
[TBL] [Abstract][Full Text] [Related]
14. ZNF322A-mediated protein phosphorylation induces autophagosome formation through modulation of IRS1-AKT glucose uptake and HSP-elicited UPR in lung cancer.
Cheung CHY; Hsu CL; Lin TY; Chen WT; Wang YC; Huang HC; Juan HF
J Biomed Sci; 2020 Jun; 27(1):75. PubMed ID: 32576196
[TBL] [Abstract][Full Text] [Related]
15. A single extra copy of Dscr1 improves survival of mice developing spontaneous lung tumors through suppression of tumor angiogenesis.
Shin J; Lee JC; Baek KH
Cancer Lett; 2014 Jan; 342(1):70-81. PubMed ID: 24051307
[TBL] [Abstract][Full Text] [Related]
16. Oct4 transcriptionally regulates the expression of long non-coding RNAs NEAT1 and MALAT1 to promote lung cancer progression.
Jen J; Tang YA; Lu YH; Lin CC; Lai WW; Wang YC
Mol Cancer; 2017 Jun; 16(1):104. PubMed ID: 28615056
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic targeting of YY1/MZF1 axis by MZF1-uPEP inhibits aerobic glycolysis and neuroblastoma progression.
Fang E; Wang X; Wang J; Hu A; Song H; Yang F; Li D; Xiao W; Chen Y; Guo Y; Liu Y; Li H; Huang K; Zheng L; Tong Q
Theranostics; 2020; 10(4):1555-1571. PubMed ID: 32042322
[TBL] [Abstract][Full Text] [Related]
18. YY1 targets tubulin polymerisation-promoting protein to inhibit migration, invasion and angiogenesis in pancreatic cancer via p38/MAPK and PI3K/AKT pathways.
Chen Q; Yang C; Chen L; Zhang JJ; Ge WL; Yuan H; Meng LD; Huang XM; Shen P; Miao Y; Jiang KR
Br J Cancer; 2019 Nov; 121(11):912-921. PubMed ID: 31631174
[TBL] [Abstract][Full Text] [Related]
19. YY1 suppresses proliferation and migration of pancreatic ductal adenocarcinoma by regulating the CDKN3/MdM2/P53/P21 signaling pathway.
Liu D; Zhang J; Wu Y; Shi G; Yuan H; Lu Z; Zhu Q; Wu P; Lu C; Guo F; Chen J; Jiang K; Miao Y
Int J Cancer; 2018 Apr; 142(7):1392-1404. PubMed ID: 29168185
[TBL] [Abstract][Full Text] [Related]
20. The HDAC2/YY1/c-Myc signaling axis regulates lung cancer cell migration and proliferation.
Ali A; Ali A; Devi HS; Daddam JR; Sarwar R; Badrealam FK
Environ Toxicol; 2023 Aug; 38(8):1989-2001. PubMed ID: 37163306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]